Burning Rock Announces Changes to Management and Board of Directors

Company Changes - Mr. Leo Li has resigned as a director and chief financial officer of Burning Rock Biotech Limited, effective September 27, 2024, citing personal reasons and confirming no disagreements with the Board or the Company [1][2] - Ms. Xiaozhi Hu, who has been with the Company since May 2014, will take over financial operations and reporting, directly reporting to Mr. Yusheng Han, the chairman and CEO [2] Company Overview - Burning Rock Biotech Limited focuses on next generation sequencing (NGS) technology in precision oncology, offering NGS-based therapy selection testing for late-stage cancer patients and cancer early detection services [3]